Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 45

Sort by

Sort Order Select

Journal Articles

Blinatumomab Added to Chemotherapy Improves Disease-Free Survival in Newly Diagnosed NCI Standard Risk Pediatric B-Acute Lymphoblastic Leukemia: Results from the Randomized Children's Oncology Group Study AALL1731

Blood (2024) 144 (Supplement 1): 1.

https://doi.org/10.1182/blood-2024-207450

Published: 2024

Journal Articles

Prognostic Impact of t(1;19) in Pediatric B-Cell Acute Lymphoblastic Leukemia (B-ALL) Patients Treated on Contemporary Children's Oncology Group (COG) Protocols

Ashley Pinchinat, John A. Kairalla, Meenakshi Devidas, Andrew J. Carroll, Mary Shago, Anne Angiolillo, Michael J. Burke, Wanda L. Salzer, Naomi J. Winick, Mignon L. Loh, David T. Teachey, Elizabeth A. Raetz, Karen R Rabin, Rachel E. Rau, Sumit Gupta

Blood (2024) 144 (Supplement 1): 315.

https://doi.org/10.1182/blood-2024-198507

Published: 2024

Journal Articles

Genomic Biomarkers of Poor Outcome in Patients with T-Cell Lymphoblastic Lymphoma

Blood (2024) 144 (Supplement 1): 313.

https://doi.org/10.1182/blood-2024-203827

Published: 2024

Journal Articles

TCL1A Is Associated with Blinatumomab Response and Immune Activation in Pediatric B-ALL

Blood (2024) 144 (Supplement 1): 634.

https://doi.org/10.1182/blood-2024-203756

Published: 2024

Journal Articles

Immunoglobulin Sequencing Biologically Distinguishes B-Lymphoblastic Lymphoma from Acute Lymphoblastic Leukemia and Reveals a Spectrum of Disease Dissemination across Clinical Stages

Carol Fries Simpson, Lik Wee Lee, Hongyue Wang, Diana G. Adlowitz, Philip Rock, Brent L. Wood, Rachel E. Rau, Kara L. Davis, Anne Angiolillo, Meenakshi Devidas, David T. Teachey, Karen R Rabin, Birte Wistinghausen, Donald Barkauskas, Robert J. Hayashi, Richard Burack, Carl E Allen, Michelle L. Hermiston, Ilan R. Kirsch

Blood (2024) 144 (Supplement 1): 2838.

https://doi.org/10.1182/blood-2024-201634

Published: 2024

Journal Articles

’Roids without rage via B-cell–targeted ADC?

Rachel E. Rau

Blood (2024) 144 (7): 686–687.

https://doi.org/10.1182/blood.2024025123

Published: 2024

Journal Articles

IFN-γ and CD38 in AML: a T-cell engagement made in heaven?

Adam J. Lamble, Rachel E. Rau

Blood (2024) 143 (16): 1556–1557.

https://doi.org/10.1182/blood.2023023786

Published: 2024

Journal Articles

Efficacy and Safety of Recombinant Erwinia Asparaginase (JZP458) in Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL): Complete Follow-up of the Children's Oncology Group (COG) AALL1931 Study

Luke Maese, Mignon L. Loh, Mi Rim Choi, Tong Lin, Etsuko Aoki, Shirali Agarwal, Vijayalakshmi Chandrasekaran, Yali Liang, Suzette Girgis, Cuiping Chen, Robert Iannone, Lewis B. Silverman, Elizabeth A. Raetz, Rachel E. Rau

Blood (2023) 142 (Supplement 1): 1498.

https://doi.org/10.1182/blood-2023-172577

Published: 2023

Journal Articles

Immunogenicity of Recombinant Erwinia asparaginase (JZP458) for Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)

Luke Maese, Mignon L. Loh, Mi Rim Choi, Yali Liang, Etsuko Aoki, Shane Roller, Tong Lin, Shirali Agarwal, Vijayalakshmi Chandrasekaran, Robert Iannone, Lewis B. Silverman, Elizabeth A. Raetz, Rachel E. Rau

Blood (2023) 142 (Supplement 1): 5908.

https://doi.org/10.1182/blood-2023-179533

Published: 2023

Journal Articles

DNMT3A Regulates Megakaryocyte-Primed HSC Lineage Fate Decisions

Sarah Waldvogel, Rachel E. Rau, Virginia Camacho, Ashlyn G. Laidman, Anna Guzman, Alejandra G Martell, Kellie Machlus, Margaret Goodell

Blood (2023) 142 (Supplement 1): 1303.

https://doi.org/10.1182/blood-2023-187363

Published: 2023

Journal Articles

Recombinant Erwinia asparaginase (JZP458) in acute lymphoblastic leukemia: results from the phase 2/3 AALL1931 study

Luke Maese, Mignon L. Loh, Mi Rim Choi, Tong Lin, Etsuko Aoki, Michelle Zanette, Shirali Agarwal, Robert Iannone, Jeffrey A. Silverman, Lewis B. Silverman, Elizabeth A. Raetz, Rachel E. Rau

Blood (2023) 141 (7): 704–712.

https://doi.org/10.1182/blood.2022016923

Published: 2023

Includes: Supplemental data

Journal Articles

Relocalization of PU.1 Underlies the On- and Off-Tumor Effects of SWI/SNF Blockade in AML

Courtney Chambers, Kristen Kurtz, Andrew Henry Lewis, Katharina Wohlan, Yuen San Chan, Katerina Cermakova, Milan Dejmek, Michal Sala, Rogelio Aguilar, Mario Loeza Cabrera, Radim Nencka, H. Daniel Lacorazza, Rachel E. Rau, H. Courtney Hodges

Blood (2022) 140 (Supplement 1): 2242–2243.

https://doi.org/10.1182/blood-2022-165396

Published: 2022

Journal Articles

Combination of the Kdm-Family Inhibitor, Jib-04, Improves Response to Acute Myeloid Leukemia Cells to Venetoclax

Katharina Wohlan, Dandan Fan, Anna Guzman, Jianzhong Su, Margaret A. Goodell, Rachel E. Rau

Blood (2022) 140 (Supplement 1): 5953–5954.

https://doi.org/10.1182/blood-2022-160199

Published: 2022

Journal Articles

Efficacy, Safety, and Population Pharmacokinetic Modeling of Intravenous Recombinant Erwinia Asparaginase (JZP458) in Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma: Results from Study AALL1931

Luke Maese, Mignon L. Loh, Mi Rim Choi, Tong Lin, Etsuko Aoki, Shirali Agarwal, Xiaotian Wu, Robert Iannone, Jeffrey A. Silverman, Lewis B. Silverman, Elizabeth A. Raetz, Rachel E. Rau

Blood (2022) 140 (Supplement 1): 8969–8970.

https://doi.org/10.1182/blood-2022-160192

Published: 2022

Journal Articles

Cohesin Gene Haploinsufficiency Does Not Prevent Development of Inv(16) Acute Myeloid Leukemia

Shannon E. Conneely, Jason H. Rogers, Rogelio Aguilar, Kristen J Kurtz, Paul P. Liu, Margaret A. Goodell, Debananda Pati, Rachel E. Rau

Blood (2022) 140 (Supplement 1): 5868–5869.

https://doi.org/10.1182/blood-2022-165368

Published: 2022

Journal Articles

Initial Results from a Phase 2/3 Study of Recombinant Erwinia Asparaginase (JZP458) in Patients with Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL) Who Are Allergic/Hypersensitive to E. coli-Derived Asparaginases

Luke Maese, Mignon L. Loh, Tong Lin, Etsuko Aoki, Michelle Zanette, Shirali Agarwal, Jeffrey A. Silverman, Mi Rim Choi, Lewis B. Silverman, Elizabeth A. Raetz, Rachel E. Rau

Blood (2021) 138 (Supplement 1): 2307.

https://doi.org/10.1182/blood-2021-147023

Published: 2021

Journal Articles

Blinatumomab Associated Seizure Risk in Patients with Down Syndrome and B-Lymphoblastic Leukemia: An Interim Report from Children's Oncology Group (COG) Study AALL1731

Amanda M. Li, Karen R Rabin, John Kairalla, Cindy Wang, Meenakshi Devidas, Olga Militano, Maki Okada, Johann K Hitzler, Anne L Angiolillo, Elizabeth A. Raetz, Mignon L. Loh, Sumit Gupta, Rachel E. Rau

Blood (2021) 138 (Supplement 1): 2304.

https://doi.org/10.1182/blood-2021-148967

Published: 2021

Journal Articles

A viral cause of APL

Rachel E. Rau

Blood (2021) 138 (18): 1653–1655.

https://doi.org/10.1182/blood.2021013630

Published: 2021

Journal Articles

Impact of Race/Ethnicity on Pediatric Core Binding Factor AML Outcomes and Response to Gemtuzumab Ozogamicin

Shannon E. Conneely, MD, Casey L. McAtee, MD, Rachel E. Rau, MD

Blood (2020) 136 (Supplement 1): 10–11.

https://doi.org/10.1182/blood-2020-138890

Published: 2020

Journal Articles

Effects of Race and Ethnicity on Clinical Features, Tumor Genetics and Outcome in Children with KMT2A Rearranged Acute Myeloid Leukemia

Casey L. McAtee, MD, Joseph Lubega, MBChB, MPH, Michael E. Scheurer, PhD MPH, Rachel E. Rau, MD

Blood (2020) 136 (Supplement 1): 34.

https://doi.org/10.1182/blood-2020-136737

Published: 2020

NARROW

Blinatumomab Added to Chemotherapy Improves Disease-Free Survival in Newly Diagnosed NCI Standard Risk Pediatric B-Acute Lymphoblastic Leukemia: Results from the Randomized Children's Oncology Group Study AALL1731

Prognostic Impact of t(1;19) in Pediatric B-Cell Acute Lymphoblastic Leukemia (B-ALL) Patients Treated on Contemporary Children's Oncology Group (COG) Protocols

Genomic Biomarkers of Poor Outcome in Patients with T-Cell Lymphoblastic Lymphoma

TCL1A Is Associated with Blinatumomab Response and Immune Activation in Pediatric B-ALL

Immunoglobulin Sequencing Biologically Distinguishes B-Lymphoblastic Lymphoma from Acute Lymphoblastic Leukemia and Reveals a Spectrum of Disease Dissemination across Clinical Stages

’Roids without rage via B-cell–targeted ADC?

IFN-γ and CD38 in AML: a T-cell engagement made in heaven?

Efficacy and Safety of Recombinant Erwinia Asparaginase (JZP458) in Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL): Complete Follow-up of the Children's Oncology Group (COG) AALL1931 Study

Immunogenicity of Recombinant Erwinia asparaginase (JZP458) for Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)

DNMT3A Regulates Megakaryocyte-Primed HSC Lineage Fate Decisions

Recombinant Erwinia asparaginase (JZP458) in acute lymphoblastic leukemia: results from the phase 2/3 AALL1931 study

Relocalization of PU.1 Underlies the On- and Off-Tumor Effects of SWI/SNF Blockade in AML

Combination of the Kdm-Family Inhibitor, Jib-04, Improves Response to Acute Myeloid Leukemia Cells to Venetoclax

Efficacy, Safety, and Population Pharmacokinetic Modeling of Intravenous Recombinant Erwinia Asparaginase (JZP458) in Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma: Results from Study AALL1931

Cohesin Gene Haploinsufficiency Does Not Prevent Development of Inv(16) Acute Myeloid Leukemia

Initial Results from a Phase 2/3 Study of Recombinant Erwinia Asparaginase (JZP458) in Patients with Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL) Who Are Allergic/Hypersensitive to E. coli-Derived Asparaginases

Blinatumomab Associated Seizure Risk in Patients with Down Syndrome and B-Lymphoblastic Leukemia: An Interim Report from Children's Oncology Group (COG) Study AALL1731

A viral cause of APL

Impact of Race/Ethnicity on Pediatric Core Binding Factor AML Outcomes and Response to Gemtuzumab Ozogamicin

Effects of Race and Ethnicity on Clinical Features, Tumor Genetics and Outcome in Children with KMT2A Rearranged Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only